Drug intelligence / Profile preview

allogeneic fibroblast injection

Development stage
Preclinical
Lead developer
FibroX Therapeutics
Modality
Cell Therapies
Administration
Intralesional
01

Overview

Allogeneic fibroblast injection is a cell therapy product being developed by the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine for the treatment of intervertebral disc degeneration (IDD). The therapy involves the isolation and expansion of fibroblasts from discarded human foreskin tissue, which are then formulated for injection into the degenerative disc. The mechanism of action involves inducing fibrotic stabilization of the intervertebral disc to restore structural integrity and alleviate lumbar back pain. Current development efforts are focused on standardizing manufacturing and quality control processes using tissue samples obtained from male circumcision procedures.

Other names
allogeneic fibroblastsforeskin-derived allogeneic fibroblast injection

Beyond the preview

Go deeper on allogeneic fibroblast injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic fibroblast injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call